Oral COTI-2 is Effective Against Aggressive Triple Negative Human Breast Cancer
Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced positive test results today from a series of anim…
Critical Outcome Technologies Inc. (COTI) (TSX Venture: COT) announced positive test results today from a series of anim…
Das Biotechnologie-Unternehmen 4SC AG(Frankfurt, Prime Standard: VSC), das sich auf die Erforschung und Entwicklung von…
The German company NeuroProof GmbH has developed a database containing the electro-physiological action profiles of over…
Due to Unforeseen Timing Circumstances with NCAA Gameday Program Publisher, Professional Sports Publications, XenaCare W…
YM BioSciences Inc. (NYSE Amex: YMI, TSX:YM), announces that it filed a Form 6K describing that certain US patents for n…
DeveloGen AG, a company focused on the discovery and development of therapies for the treatment of diabetes and other me…
Daetwyler is investing in further expansion of its Pharmaceutical Packaging Division. The division, operating as Helvoet…
In a study published online today in Nature, a team of researchers from Penn State University and the University New Sou…
Never say never again. This James Bond movie title certainly applies to medical research. Only a few years ago, cultivat…
QIAGEN N.V. (Nasdaq: QGEN; Frankfurt, Prime Standard: QIA) today announced the results of operations for the fourth quar…